Human cytomegalovirus UL144 is associated with viremia and infant development sequelae in congenital infection.
Human cytomegalovirus (HCMV) strains may be genotyped based on polymorphisms that exist within the UL144 gene, which is one of 19 viral genes lost in attenuated laboratory strains. In the present study, UL144 genotypes in congenitally infected babies (congenital cytomegalovirus [cCMV]) were determined, and the relationship between the genotype, viral load, cytokine profile, and patient developmental outcome was investigated. All cCMV infections identified during 2006 and 2007 were included (n = 29). A portion of the infants were clinically assessed at birth and at 12 to 18 months postinfection for cCMV clinical sequelae (n = 18/29). The plasma viral load (PVL) was requested for 23/29 patients, and the UL144 genotype was determined (n = 27/29). The cytokine profile in patient plasma or serum was assessed (n = 20/29). UL144 genotypes A, B, and C were detected within the cCMV population at 33.3%, 29.6%, and 25.9%, respectively. UL144 A and C were associated with a high PVL (P < 0.04). Furthermore, a significant association between the developmental outcome and UL144 A and C was observed (P < 0.04). Only patients infected with UL144 B and A/B were described as having a normal clinical outcome. In addition, a significant correlation between interleukin 10 (IL-10) levels and the PVL was observed (P < 0.04); however, there was no association between the genotype and the cytokine profile. The present study determined that the specific detection of UL144 genotypes A and C was indicative of serious cCMV infection and more likely to lead to long-term cCMV-associated clinical manifestations. The inclusion of HCMV UL144 genotyping along with the recommended PVL monitoring following cCMV diagnosis may aid prediction of the clinical outcome.
Waters
Allison
A
National Virus Reference Laboratory, University College Dublin, Belfield, Dublin 4, Ireland.
Hassan
Jaythoon
J
De Gascun
Cillian
C
Kissoon
Ghia
G
Knowles
Susan
S
Molloy
Eleanor
E
Connell
Jeff
J
Hall
William W
WW
D002657:Child Development; D016207:Cytokines / Q000097:blood; D003587:Cytomegalovirus / Q000235:genetics* / Q000472:pathogenicity*; D003586:Cytomegalovirus Infections / Q000151:congenital* / Q000473:pathology* / Q000821:virology; D004279:DNA, Viral / Q000737:chemistry / Q000235:genetics; D005838:Genotype; D006803:Human Development; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008562:Membrane Glycoproteins / Q000235:genetics*; D008969:Molecular Sequence Data; D010949:Plasma / Q000276:immunology / Q000821:virology; D011110:Polymorphism, Genetic; D017422:Sequence Analysis, DNA; D044967:Serum / Q000276:immunology / Q000821:virology; D019562:Viral Load; D014764:Viral Proteins / Q000235:genetics*; D014766:Viremia / Q000821:virology*; D014774:Virulence; D037521:Virulence Factors / Q000235:genetics
D016207:Cytokines; D004279:DNA, Viral; D008562:Membrane Glycoproteins; C119624:UL144 ORF protein, Human herpesvirus 5; D014764:Viral Proteins; D037521:Virulence Factors
Rev Med Virol. 2007 Sep-Oct;17(5):355-63
17542052
J Infect Dis. 2007 Dec 1;196(11):1719-20
18008260
Acta Paediatr. 2001 Oct;90(10):1176-81
11697431
Clin Exp Immunol. 2007 Mar;147(3):465-71
17302895
J Infect Dis. 2005 Jan 15;191(2):227-33
15609232
J Infect Dis. 2006 Aug 15;194(4):464-73
16845629
J Virol. 1996 Jan;70(1):78-83
8523595
Arch Virol. 2008;153(4):667-74
18273679
J Clin Microbiol. 2006 Mar;44(3):1108-10
16517906
Eur J Endocrinol. 2005 Feb;152(2):207-10
15745927
Lancet. 1984 Dec 1;2(8414):1242-5
6150279
J Clin Microbiol. 2005 Jan;43(1):25-9
15634946
J Gen Virol. 2004 May;85(Pt 5):1301-1312
15105547
EMBO J. 2006 Sep 20;25(18):4390-9
16932746
Pediatrics. 2006 Jan;117(1):e76-83
16326692
J Infect Dis. 2002 Oct 15;186(8):1057-64
12355354
Eur J Pediatr. 2001 Jun;160(6):345-50
11421413
J Pediatr. 2005 Jun;146(6):817-23
15973325
BMC Public Health. 2005 Jun 20;5:70
15967030
Proc Natl Acad Sci U S A. 2005 Sep 13;102(37):13218-23
16131544
J Immunol. 1999 Jun 15;162(12):6967-70
10358135
Bioinformatics. 1998;14(9):817-8
9918953
J Med Virol. 2001 Sep;65(1):90-6
11505449
J Virol. 1999 Dec;73(12):10040-50
10559318
Hum Immunol. 2004 May;65(5):500-6
15172450